ACOX2 and steatosis: Thus, even if diminished ACOX2 levels alone, as caused by FDO treatment, are assumed to be not sufficient for steatosis induction, the combination of the molecular effects of triazoles with ACOX2 inhibition by FDO might cause a more than additive effect, driven by toxicodynamic synergies of the different compounds.